SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-22-003468
Filing Date
2022-03-11
Accepted
2022-03-11 16:34:56
Documents
74
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K clsd-20211231.htm   iXBRL 10-K 3031158
2 EX-10.14 clsd-ex10_14.htm EX-10.14 20792
3 EX-23.1 clsd-ex23_1.htm EX-23.1 13885
4 EX-31.1 clsd-ex31_1.htm EX-31.1 16571
5 EX-31.2 clsd-ex31_2.htm EX-31.2 16534
6 EX-32.1 clsd-ex32_1.htm EX-32.1 11129
7 GRAPHIC img139656879_0.jpg GRAPHIC 35686
8 GRAPHIC img139656879_1.jpg GRAPHIC 46523
9 GRAPHIC img139656879_2.jpg GRAPHIC 91898
  Complete submission text file 0000950170-22-003468.txt   10578523

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT clsd-20211231_lab.xml EX-101.LAB 515367
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT clsd-20211231.xsd EX-101.SCH 57108
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT clsd-20211231_pre.xml EX-101.PRE 379886
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT clsd-20211231_def.xml EX-101.DEF 233205
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT clsd-20211231_cal.xml EX-101.CAL 42486
68 EXTRACTED XBRL INSTANCE DOCUMENT clsd-20211231_htm.xml XML 1862925
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37783 | Film No.: 22733632
SIC: 2834 Pharmaceutical Preparations